In applications to equivalence testing, tests are required to maintain a specified power, rather than Type I error rate: such tests can be constructed by defining the standardised test statistics used in the significance level approach with respect to appropriately chosen hypotheses.
Multiple comparisons will be used to test a priori and post-hoc hypotheses, appropriately adjusted to maintain the nominated Type I error rate.
This study supports the hypothesis that appropriately applied management results in consistent desired outcomes regardless of increased simulated atmospheric nitrogen depositions.
If the latter, these examples may more appropriately relate to the hypothesis of species-site mismatch (see above), but in the context of well-suited genotypes rather than species.
We report an assessment of the hypothesis that appropriately transformed tree-ignorant metrics have similar statistical power to tree-aware approaches by performing a systematic comparison of nine coevolution algorithms.
However, studies that can appropriately address the latter hypothesis will be complex in their design and execution because of the relatively small effect sizes involved and the tissue- and cell-specific nature of age-related changes (Heijmans & Mill, 2012).
Given these reasons, Tobit models are used to correct for such limited dependent variables (Tobin 1958), allowing us to estimate hypotheses more appropriately.
Post-Scholastic ridicule of the sort that was directed at the alleged ontological excesses of the Schoolmen, e.g., the query "How many angels may fit upon the point of a needle?", is quite appropriately directed at metaphysical hypotheses of this sort.
Rather, based on previous work [ 19], for both experiments we tested a set of a priori hypotheses (using appropriately adjusted error terms).
FCIA is based on the hypothesis that an appropriately designed stilbene-antigen analogue probe will suffer considerable steric hindrance to trans-cis photoisomerization when bound within the combined constraints of both an antibody binding site and a second globular protein.
